Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Shareholders' Equity (Details)

v3.22.1
Shareholders' Equity (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 2 Months Ended 12 Months Ended
Dec. 20, 2021
Jul. 08, 2020
USD ($)
$ / shares
shares
Jun. 12, 2020
$ / shares
shares
Mar. 09, 2020
USD ($)
$ / shares
shares
Feb. 12, 2020
Feb. 10, 2020
USD ($)
$ / shares
shares
Jan. 09, 2020
USD ($)
$ / shares
shares
May 10, 2019
Apr. 04, 2019
USD ($)
$ / shares
shares
Aug. 16, 2021
USD ($)
$ / shares
shares
Mar. 31, 2021
USD ($)
shares
Apr. 28, 2020
₪ / shares
shares
Dec. 31, 2019
shares
Sep. 30, 2019
shares
May 22, 2019
USD ($)
$ / shares
shares
Jan. 18, 2019
USD ($)
$ / shares
shares
Mar. 31, 2021
USD ($)
shares
May 31, 2020
USD ($)
$ / shares
shares
Dec. 31, 2021
₪ / shares
shares
Dec. 31, 2020
USD ($)
shares
Dec. 31, 2019
USD ($)
shares
Dec. 31, 2020
₪ / shares
Nov. 28, 2013
₪ / shares
shares
Shareholders' Equity (Details) [Line Items]                                              
Stockholders equity change In ratio description               (1) ADS representing two (2) ordinary shares to a new ratio of one (1) ADS representing thirty (30) ordinary shares. For ADS holders, the ratio change had the same effect as a one-for-fifteen reverse ADS split. All ADS and per ADS data in the financial statements and their related notes have been retroactively adjusted for all periods presented to reflect the ratio change.                              
Sold an aggregate shares                                     356,803 356,803      
Ordinary shares issued       20,250,000                 996,690 19,934,355       31,000,020          
Aggregate purchase price (in Dollars) | $                 $ 3,200           $ 6,000 $ 2,350              
Issuance cost (in Dollars) | $                 $ 414           $ 540 $ 428              
Ordinary shares issued                                     30        
Aggregate shares             22,278,540                                
Reduced exercise price (in Dollars per share) | $ / shares             $ 3.25                                
Gross proceeds (in Dollars) | $   $ 3,400   $ 1,012     $ 2,400                     $ 1,550   $ 75 $ 115    
Issue of new unregistered warrants   852,750         22,278,540                                
Deemed dividend (in Dollars) | $             $ 715                                
Securities purchase agreement, description         the Company completed a public offering with certain institutional investors pursuant to which the Company issued and sold (i) 1,825,000 units, each unit consisting of one ADS, and one warrant to purchase one ADS, at a price of USD 1.50 per unit, and (ii) 1,508,334 pre-funded units each pre-funded unit consisting of one pre-funded warrant to purchase one ADS and one warrant, at a price of USD 1.49 per pre-funded unit.                                    
Gross proceeds from offering (in Dollars) | $           $ 5,000                                  
Expiring date           Feb. 10, 2025                                  
Increase authorized capital                       1,000,000,000                      
Par value (in New Shekels per share) | ₪ / shares                       ₪ 0.25             ₪ 0.25     ₪ 0.25 ₪ 0.25
Stock issuance agreement, description     On June 12, 2020, the Company completed a registered direct offering with certain institutional and accredited investors pursuant to which it sold an aggregate of 3,902,440 ADSs at a purchase price of $2.05 per ADS for aggregate gross proceeds of approximately $8,000 prior to deducting the placement agent’s fees and estimated offering expenses payable by the Company.                                        
Aggregate number of ADS percentage   7.50% 7.50%                                        
Exercise price per ADS (in Dollars per share) | $ / shares   $ 2.5 $ 2.5             $ 2                          
Warrants to purchase aggregate ADS shares   127,913                                          
Exercise price (in Dollars per share) | $ / shares   $ 2.5                                          
Ordinary shares                                       1,350,000      
Total consideration amount (in Dollars) | $                     $ 2,744           $ 2,744            
Fair value amount (in Dollars) | $                     $ 68           $ 68            
Purchase agreement description                   On August 16, 2021, the Company completed a registered direct offering with an institutional investor pursuant to which it sold (i) 57,000,000 ordinary shares represented by 1,900,000 ADSs, and (ii) a pre-funded warrant to purchase 93,000,000 ordinary shares represented by 3,100,000 ADSs at an offering price of $2.00 per ADS and $1.999 per pre-funded warrant, for aggregate gross proceeds of approximately $10,000 (without taking into account any proceeds from any future exercises of warrants issued in the concurrent private placement), before deducting the placement agent’s fees and other estimated offering expenses payable by the Company.   The Company has also sold to the investor, in a concurrent private placement, unregistered warrants to purchase up to an aggregate of 5,000,000 ADSs. The warrants have an exercise price of $ 2.00 per ADS and are exercisable at any time upon issuance and will expire three years following the effectiveness of an initial resale registration statement registering the ADSs issuable upon the exercise of the warrants.   As of the financial statements date, the Company received a total of $ 9,997 and issued 57,000,000 ordinary shares represented by 1,900,000 ADSs and 93,000,000 ordinary shares represented by 3,100,000 ADSs following the exercise of the pre-funded warrants (issuance expenses were $1,307).    17. On December 20, 2021, the Company entered into a warrant exercise agreement (the “Exercise Agreement”) with an institutional investor who is the holder of certain existing warrants to purchase Company’s ordinary shares, par value NIS 0.25 per share, represented by ADSs issued by the Company in a registered direct offering consummated in August 2021.                          
Total received amount (in Dollars) | $                   $ 9,997                          
Ordinary shares                   93,000,000                          
Issuance expenses amount (in Dollars) | $                   $ 1,307                          
Exercise agreement description Pursuant to the Exercise Agreement, the holder agreed to exercise in cash its warrants to purchase up to an aggregate of 150,000,000 Ordinary Shares represented by 5,000,000 ADSs having an exercise price of $2.00 per ADS, at an exercise price of $2.00 per ADS, for gross proceeds to the Company of $10 million, prior to deducting placement agent fees and offering expenses (which amounted to $0.98 million).   Under the Exercise Agreement, the Company also agreed to issue to the holder new unregistered warrants to purchase up to 180,000,000 Ordinary Shares represented by 6,000,000 ADSs (the “Private Placement Warrants”). The Private Placement Warrants will be immediately exercisable, will expire five years following the effectiveness of an initial resale registration statement registering the ADSs issuable upon the exercise of the warrants, and have an exercise price of $2.00 per ADS.   Pursuant to the terms of the Exercise Agreements, the holder agreed to exercise the warrants while receiving a-120% warrants coverage, thereby creating a benefit to this warrant holder. As such, the Company recorded a deemed dividend in the amount of $ 2,590.                                            
ADS [Member]                                              
Shareholders' Equity (Details) [Line Items]                                              
Sold an aggregate shares                 328,205           1,500,000 149,206              
Ordinary shares issued       675,000                           1,033,334          
Warrants to purchase additional shares                               149,206              
Warrant exercise price (in Dollars per share) | $ / shares                               $ 19.5              
Purchase aggregate warrant                 328,205           1,500,000 7,460              
Exercise prices (in Dollars per share) | $ / shares     $ 2.5     $ 1.875     $ 12.9           $ 4                
Aggregate warrant purchased     292,683           16,410 5,000,000         75,000                
Aggregate shares             742,618                                
Issue of new unregistered warrants   1,705,000 1,951,220                                        
Exercise price subject to adjustment (in Dollars per share) | $ / shares             $ 3.45                                
Compensation warrant exercisable           250,000                                  
Share price (in Dollars per share) | $ / shares       $ 1.5                           $ 1.5          
Exercise price per ADS (in Dollars per share) | $ / shares   $ 2                                          
Ordinary shares                   1,900,000 35,000           1,697,561            
Ordinary shares                   3,100,000                          
ADS [Member] | Minimum [Member]                                              
Shareholders' Equity (Details) [Line Items]                                              
Exercise prices (in Dollars per share) | $ / shares             12.9                                
ADS [Member] | Maximum [Member]                                              
Shareholders' Equity (Details) [Line Items]                                              
Exercise prices (in Dollars per share) | $ / shares             $ 78.75                                
Ordinary Shares [Member]                                              
Shareholders' Equity (Details) [Line Items]                                              
Sold an aggregate shares                 9,846,156                            
Ordinary shares issued                 9,846,156           45,000,000 4,476,192       1,350,000 996,690    
Warrants to purchase additional shares                               4,476,192              
Ordinary shares issued                 492,308           45,000,000 223,810             2,500,000
Ordinary shares issued                             2,250,000                
Aggregate shares                                     1,050,000        
Gross proceeds (in Dollars) | $                                       $ 100 $ 72    
Ordinary shares                   57,000,000 1,050,000           50,926,830            
Private Placement Warrants [Member] | ADS [Member]                                              
Shareholders' Equity (Details) [Line Items]                                              
Issue of new unregistered warrants             742,618